CHARACTERISTICS OF THROMBOPHILIC GENE MUTATIONS IN WOMEN WITH A HISTORY OF MISCARRIAGE AT THE NATIONAL HOSPITAL OF OBSTETRICS AND GYNECOLOGY

Du Vũ Văn, Mai Trần Thị Phương, Hùng Đặng Quang, Tốt Đặng Văn, Hương Lê Thị Ngọc, Hằng Nguyễn Thị

Main Article Content

Abstract

Background: Thrombophilia is a group of hereditary or acquired prothrombotic disorders, has recently attracted considerable attention and remains controversial. Objective: This study aimed to describe the characteristics of thrombophilic gene mutations and several related factors in women with a history of miscarriage. Methods: A cross-sectional study was conducted on 365 women with a history of miscarriage of unknown cause who attended the National Hospital of Obstetrics and Gynecology in 2023. Results: Most women with a history of miscarriage carried at least one thrombophilic gene mutation. However, no significant difference was observed in the mutation rates between women with a single miscarriage and those with recurrent miscarriage. The two most frequently identified mutations were PAI-1 and MTHFR A1298C, accounting for 81% and 47.9%, respectively. Prothrombin/FII 20210A and Factor V Leiden mutations were rare and are not considered major causes of miscarriage in Vietnamese women. No correlation was found between the total number of mutated alleles and the occurrence of recurrent miscarriage.

Article Details

References

1. European Society of Human Reproduction and Embryology. Recurrent Pregnancy Loss. Published online 2017.
2. Liu X, Chen Y, Ye C, et al. Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod. 2021;36(5): 1213-1229. doi:10.1093/ humrep/deab010
3. Abu-Heija A. Thrombophilia and Recurrent Pregnancy Loss. Sultan Qaboos Univ Med J. 2014;14(1):e26-e36.
4. Robinson GE. Pregnancy loss. Best Practice & Research Clinical Obstetrics & Gynaecology. 2014; 28(1): 169-178. doi:10.1016/j.bpobgyn .2013.08.012
5. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost. 1999;82(1):6-9.
6. Lan HTN, Tùng TS, Giang PTT, et al. Nghiên cứu một số biến thể di truyền gây tăng nguy cơ huyết khối ở phụ nữ mất thai tái diễn. VMJ. 2023;526(1A). doi:10.51298/vmj.v526i1A.5306
7. Agersnap I, Nissen PH, Hvas AM. The Role of Plasminogen Activator Inhibitor Type 1 (PAI-1) in Placenta-Mediated Pregnancy Complications: A Systematic Review. Semin Thromb Hemost. 2022; 48(5): 607-624. doi:10.1055/s-0041-1742082
8. Li X, Liu Y, Zhang R, Tan J, Chen L, Liu Y. Meta-Analysis of the Association between Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Recurrent Pregnancy Loss. Med Sci Monit. 2015;21:1051-1056. doi:10.12659/MSM.892898
9. Liu X, Chen Y, Ye C, et al. Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod. 2021;36(5): 1213-1229. doi:10.1093/ humrep/deab010
10. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361(9361):901-908. doi: 10.1016/S0140-6736(03)12771-7